Jubereq Injection
Product Images NDC 69448-022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Jubereq (NDC 69448-022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Biopharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Jubereq 01)

Figure 1 (Jubereq 01)
A line graph depicting corrected calcium levels over study days for denosumab 120 mg with 23 subjects. The x-axis represents study days from baseline to day 57, and the y-axes show corrected calcium in mmol/L (left) and mg/dL (right). The graph shows a declining trend in calcium levels with error bars at each time point.*
FDA Label Image

Logo (Jubereq 02)

FDA Label Image

Principal Display Panel (Jubereq 03)

Principal Display Panel (Jubereq 03)
Label for JUBEREQ (denosumab-desu) injection, 70 mg/mL, in a 120 mg/1.7 mL single-dose vial for subcutaneous use. The label includes the NDC 69448-022-63, manufacturer Accord BioPharma Inc., storage instructions to refrigerate at 2°C to 8°C, and a barcode. It also indicates prescription-only status.*
FDA Label Image

Principal Display Panel (Jubereq 04)

Principal Display Panel (Jubereq 04)
Packaging label for JUBEREQ (denosumab-desu) injection, 120 mg/1.7 mL (70 mg/mL) single-dose vial. Designed for subcutaneous use, the label includes storage instructions, manufacturer info (Accord BioPharma Inc. and Intas Pharmaceuticals Limited), and security sticker placement areas. The label features the NDC 69448-022-63 and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.